The Complete Guide to Surrogacy Services in Kyrgyzstan: Law, Technology and Reproductive Options for Transnational Families
Legal Framework: Surrogacy Legality and Safeguarding the Rights of International Families Kyrgyzstan has been one of the few countries in the world to explicitly support commercial surrogacy since the amendment of the Law on the Protection of Citizens’ Health in 2024. The core strengths of its legal system include: Clarity of legality: Surrogacy contracts are notarized, defining surrogacy as “an act of agreement between the potential parents and the surrogate mother,” and requiring that the surrogate mother be between the ages of 20 and 40 and have given birth to at least one healthy child.Wide range of applicants: The law does not restrict the marital status, sexual orientation or nationality of the commissioning party, so singles, the LGBTQ+ community and transnational couples can all legally apply.Parental Rights Protection: The birth certificate of a newborn child directly registers the commissioning party as the legal parent, eliminating the need for adoption procedures, and the birth document supports Apostille certification to ensure international legal validity.Legal Risks: Despite the liberalization of the policy, details such as disposal of embryos and reduction of multiple births still need to be clarified through the contract. It is recommended that the client choose an organization with a team of professional lawyers to avoid the risk of transnational legal conflicts. Medical technology: scientific support behind high success rate Kyrgyzstan’s assisted reproduction technology is known for its cost-effectiveness, and its core advantages include: Third-generation IVF technology (PGT-A):Embryo chromosome screening with 99% accuracy, 200+ genetic diseases can be ruled out, and the live birth rate is increased to 60%-70%.Timelapse dynamic culture system monitors embryo development in real time, with blastocyst formation rate exceeding 70%.Standardized medical process:Ovulation promotion protocol: antagonist protocol (Gonal-F 225 IU + Menopur 150 IU) is used with a target number of eggs acquired of 8-12 eggs/cycle and a…
